These facts led us to speculate the functions of these RDRs and HDAs in the evolution of coronaviruses. 144/145 and S 243-244, have been confirmed to block the binding sites of neutralizing antibodies. Overall, this study revealed a conservative regional pattern and the potential effect of some deletions in SARS-CoV-2 over the whole genome, providing important evidence for potential epidemic control and vaccine development. OXF BD 02 IMPORTANCEMutations in SARS-CoV-2 were studied extensively, while only the structure variations around the spike protein were discussed well in previous studies. To study the role of structural variations in virus evolution, we described the distribution of structure variations on the whole genome. Conserved patterns were found of deletions among SARS-CoV-2, SARS-CoV-2-like, and SARS-CoV-like viruses. There were 45 recurrent deletion regions (RDRs) in SARS-CoV-2 generated through the integration of deleted positions. In these regions, four high-frequency deletions parallelly appeared in multiple strains. Furthermore, in the spike protein, the deletions in SARS-CoV-2 were mainly in the N-terminal domain name, blocking the binding sites of some neutralizing antibodies, while the structural variations in SARS-related coronavirus were mainly in the N-terminal domain name and receptor binding domain name. The receptor binding domain name is usually highly related to hosting recognition. The deletions in the receptor binding domain name may play a role in host adaption. KEYWORDS:SARS-CoV-2, recurrent deletion, mutation, structural variation, adaptive evolution Since the outbreak of COVID-19 caused by SARS-CoV-2 in late 2019, this computer virus has spread globally for nearly two years. In some regions, although the vaccination rate or contamination rate has reached a relatively high level, great concerns have been raised for the continuous variation in SARS-CoV-2 on their ability to escape immune neutralization (1,2). Recently, a SARS-CoV-2 variant, B.1.617.2, also named the Delta strain by World Health Organization (WHO), has shown increased transmission and immune escape capabilities (3,4). People with previously induced antibodies still have the risk of contamination by this variant (5). Therefore, there is an urgent need to understand the molecular mechanism underlying the adaptive evolution of SARS-CoV-2. SARS-CoV-2 can take advantage of genome variation to evolve rapidly, including single nucleotide polymorphisms (SNPs) and structural variations (SVs). SVs consist of short fragment insertions, deletions, sequence reversals, and recombination, etc. Current research mainly focused on SNPs (6), but SV changes can include more nucleotides, which may have a greater impact on genomic structure or protein function. Many SVs arise during a viral passage, while only a small part can be retained and spread. These preserved deletions may have played a potential role during the evolution of SARS-CoV-2 (7). Previous studies have shown that fragment deletions have the possibility to affect the proliferation and transmission of SARS-CoV-2 (8,9). For instance, a 382-nucleotide deletion in the ORF8 protein weakening the virulence of SARS-CoV-2 was reported in the early stages of the SARS-CoV-2 epidemic in Singapore (8). A 500-532 deletion event was shown to reduce the host INF- response, a mutation that seemed to occur early in this epidemic and can be found on the nonstructural protein 1 (nsp1) (10). Another 34-nucleotide deletion was found in France around the ORF6 protein. This variant was shown to induce the overexpression of several specific cytokines, including CCL2/MCP1, PTX3, and TNF, etc., which are involved in OXF BD 02 the regulation and transduction of NF-kb signaling (11). Recently, in the B.1.1.7 lineage of SARS-CoV-2, 69-70 and 144 were found in the S protein. S 69-70 was shown to increase the viruses ability to release the S2 structure, which can augment viral infectivity OXF BD 02 and improve viral syncytium production (12). Based on a bioinformatic analysis, Reham et al. found S 144 can alter the pocket structure around the N-terminal (NTD) of the S protein and reduce the affinity between PB1 the NTD and endogenous host antibodies (13). With the accumulation of site information and structural variations, more SARS-CoV-2 variants with divergent mutations continue to appear in the literature. For instance, the B.1.1.7 variant (the Alpha strain) outbreak occurred in the United OXF BD 02 Kingdom first, then the B.1.617.2 variant (the Delta strain) outbreak happened in India. These variants have been observed to evade vaccine immunity (3,14). OXF BD 02 Four recurrent deletion regions (RDRs), including S 69-70 and S 144, in.
